30 September 2013Biotechnology

Big player: the Bavarian biotech cluster

As of May 25, 2013, Munich can claim to host the best football team in Europe. With some of the strongest players from across the world anchored by a core of home-grown talent, Bayern Munich are sweeping all before them.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Novartis bets $2bn on biologics as Xolair patents fade

27 March 2026 The Swiss pharma giant targets next-generation anti-IgE biologics as it looks to extend its dominance in the market.

Biotechnology

mRNA litigation: Who’s winning, who’s filing, and what’s next

25 March 2026 As the world moves past the pandemic, a massive legal struggle over the future of mRNA technology is just hitting its stride. LSIPR visualises the litigation defining the next era.

Biotechnology

‘Doing more with less’: In-house counsel on budgets and strategy

22 October 2025 Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.

More features

European patent offices raise fees

UPC refuses early knockout in Illumina–Element dispute

IndiaMart v CDSCO: A test of intermediary liability

CRISPR priority feud ends at USPTO as board reaches decision

Novartis bets $2bn on biologics as Xolair patents fade

WIPR debuts Global In-House Elite 2026

mRNA litigation: Who’s winning, who’s filing, and what’s next

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

Big player: the Bavarian biotech cluster

More on this story

Editor's picks

Editor's picks

More features